Biomet Sales Encouraging for Industry

By · April 13, 2012 · No comments
Financial · Tagged: , , ,
Biometlogo

Biomet, Inc. reported a 5% increase in sales for the company’s third fiscal quarter on April 11. Like the groundhog, Punxsutawney Phil of Pennsylvania, the company’s sales are widely watched because Biomet is the first company to report orthopedic industry quarterly sales for the start of the year.

Biomet 3Q 2012

Sales

($ in millions)

% Change 
Total Reported Sales $708.9 5%
     Large Joints 422.7 5%
          Knees

4%
          Hips

6%
     Sports, Extremities, Trauma 92.7 16.0%
     Spine & Bone Healing 76.5 down 5%
     Dental 65.6 down 2%
     Other 51.4 8.0%

Source: Biomet, Inc.

The company reported Knees and Hips up 4% and 6%, respectively. Spine and Bone Healing fell by 5%, the fifth consecutive quarter of declines, according to Wells Fargo Analyst Larry Biegelsen. Sports, Extremities and Trauma rose 16%. “Against relatively easy comps, Biomet posted better quarterly growth in nearly all of its product categories,” wrote Jefferies & Company, Inc. Analyst Raj Denhoy in an investor note on April 11.

Posted By

Josh Sandberg has been recruiting specifically in the musculoskeletal industry for over 8 years. Throughout this time, he has been able to have a positive impact on his client’s businesses. With an educational background in Business Management, Josh is adept to discern which people will be the best fit for the company he is searching for by understanding how candidates will incorporate with the company’s culture and operational nuances. His experience as an executive in a start-up business has granted him the ability to understand what is takes to thrive in a hands–on environment, where desire and dedication are paramount for success.
←
→

© 2013 OrthoSpineNews